RG 7863

Drug Profile

RG 7863

Alternative Names: RG7863; RO 6870868

Latest Information Update: 15 Aug 2014

Price : $50

At a glance

  • Originator Roche
  • Class Antivirals
  • Mechanism of Action Toll-like receptor 7 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 24 Jul 2014 Discontinued - Phase-I for Hepatitis B (In volunteers) in Netherlands (unspecified route)
  • 01 Aug 2013 Phase-I clinical trials in Hepatitis B (In volunteers) in Netherlands (unspecified route) (NCT01911611)
  • 26 Jul 2013 Preclinical trials in Undefined indication in Switzerland before July 2013 (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top